Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMC Genomics ; 22(1): 907, 2021 Dec 18.
Artigo em Inglês | MEDLINE | ID: mdl-34922456

RESUMO

BACKGROUND: Cystic and alveolar echinococcosis caused by the tapeworms Echinococcus granulosus sensu stricto (s.s.) and E. multilocularis, respectively, are important zoonotic diseases. Protease inhibitors are crucial for the survival of both Echinococcus spp. Kunitz-type inhibitors play a regulatory role in the control of protease activity. In this study,we identified Kunitz-type domain protease inhibitors(KDPIs) present in the genomes of these two tapeworms and analyzed the gene sequences using computational, structural bioinformatics and phylogenetic approaches to evaluate the evolutionary relationships of these genes. Hi-seq transcriptome analysis showed that E. granulosus s.s. KDPIs were differentially expressed in the different developmental stages. We validated some of the genes expressed in adult worm, protoscolex and cyst germinal membrane of E. granulosus s.s. and E. multilocularis by quantitative PCR. RESULTS: A total of 19 genes from E. multilocularis and 23 genes from E. granulosus s.s. were predicted to be KDPIs with the most containing a single Kunitz-domain. A maximum likelihood method phylogenetic tree indicated that the E. granulosus s.s. and E. multilocularis Kunitz domain peptides were divided into three branches containing 9 clusters. The ratio of positively charged residues and neutral residues are different between E. multilocularis and E. granulosus s.s. KDPIs. We also found that E. multilocularis had higher percentage of sequences containing signal peptides (17/19, 89.47%) than that of E. granulosus s.s. (14/23, 60.87%). Transcript analysis showed all the E. granulosus s.s. KDPI genes were expressed differentially in four developmental stages of the worm. Transcription analysis showed that 9 KDPIs (including EG_07244,EGR_08716 and EGR_10096) were highly upregulated in adult worm, and 2 KDPIs (EG_09268 and EG_09490) were highly expressed in the cyst germinal membrane. Quantitative gene expression analysis(qPCR) of four genes confirmed the expression of these genes. EGR_08716 and its homologous gene (EmuJ_001137000) were highly and specifically expressed in adult worms of the two worms. CONCLUSIONS: A total 19 and 23 KDPIs were identified in the genomes of E. multilocularis and E. granulosus s.s. , respectively. The differential expression of these KDPIs in different stages may indicate their different roles in the different hosts. The difference in characterization of KDPIs may be associated with the different pathology of metacestode stage of these two parasites.


Assuntos
Echinococcus granulosus , Animais , Biologia Computacional , Echinococcus granulosus/genética , Filogenia , Inibidores de Proteases
2.
FASEB J ; 35(1): e21205, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33337558

RESUMO

CRISPR/Cas9-mediated genome editing shows cogent potential for the genetic modification of helminth parasites. We report successful gene knock-in (KI) into the genome of the egg of Schistosoma mansoni by combining CRISPR/Cas9 with single-stranded oligodeoxynucleotides (ssODNs). We edited the acetylcholinesterase (AChE) gene of S. mansoni targeting two guide RNAs (gRNAs), X5 and X7, located on exon 5 and exon 7 of Smp_154600, respectively. Eggs recovered from livers of experimentally infected mice were transfected by electroporation with a CRISPR/Cas9-vector encoding gRNA X5 or X7 combining with/ without a ssODN donor. Next generation sequencing analysis of reads of amplicon libraries spanning targeted regions revealed that the major modifications induced by CRISPR/Cas9 in the eggs were generated by homology directed repair (HDR). Furthermore, soluble egg antigen from AChE-edited eggs exhibited markedly reduced AChE activity, indicative that programed Cas9 cleavage mutated the AChE gene. Following injection of AChE-edited schistosome eggs into the tail veins of mice, an significantly enhanced Th2 response involving IL-4, -5, -10, and-13 was detected in lung cells and splenocytes in mice injected with X5-KI eggs in comparison to control mice injected with unmutated eggs. A Th2-predominant response, with increased levels of IL-4, -13, and GATA3, also was induced by X5 KI eggs in small intestine-draining mesenteric lymph node cells when the gene-edited eggs were introduced into the subserosa of the ileum of the mice. These findings confirmed the potential and the utility of CRISPR/Cas9-mediated genome editing for functional genomics in schistosomes.


Assuntos
Acetilcolinesterase/metabolismo , Sistemas CRISPR-Cas , Edição de Genes , Proteínas de Helminto/metabolismo , Schistosoma mansoni/enzimologia , Esquistossomose mansoni/metabolismo , Acetilcolinesterase/genética , Animais , Feminino , Proteínas de Helminto/genética , Camundongos , Schistosoma mansoni/genética , Esquistossomose mansoni/genética
3.
Parasitology ; 147(13): 1488-1498, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-32741402

RESUMO

Praziquantel (PZQ) is the drug of choice for schistosomiasis. The potential drug resistance necessitates the search for adjunct or alternative therapies to PZQ. Previous functional genomics has shown that RNAi inhibition of Ca2+/calmodulin-dependent protein kinase II (CaMKII) gene in Schistosoma adult worms significantly improved the effectiveness of PZQ. Here we tested the in vitro efficacy of 15 selective and non-selective CaMK inhibitors against Schistosoma mansoni and showed that PZQ efficacy was improved against refractory juvenile parasites when combined with these CaMK inhibitors. By measuring CaMK activity and the mobility of adult S. mansoni, we identified two non-selective CaMK inhibitors, Staurosporine (STSP) and 1Naphthyl PP1 (1NAPP1), as promising candidates for further study. The impact of STSP and 1NAPP1 was investigated in mice infected with S. mansoni in the presence or absence of a sub-lethal dose of PZQ against 2- and 7-day-old schistosomula and adults. Treatment with STSP/PZQ induced a significant (47-68%) liver egg burden reduction compared with mice treated with PZQ alone. The findings indicate that the combination of STSP and PZQ dosages significantly improved anti-schistosomal activity compared to PZQ alone, demonstrating the potential of selective and non-selective CaMK/kinase inhibitors as a combination therapy with PZQ in treating schistosomiasis.


Assuntos
Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina/antagonistas & inibidores , Praziquantel/farmacologia , Schistosoma mansoni/efeitos dos fármacos , Esquistossomose mansoni/prevenção & controle , Esquistossomicidas/farmacologia , Animais , Feminino , Fígado/parasitologia , Masculino , Camundongos , Contagem de Ovos de Parasitas
4.
Semin Immunopathol ; 42(3): 373-374, 2020 06.
Artigo em Inglês | MEDLINE | ID: mdl-32519147

RESUMO

The original version of this article inadvertently missed out to display the correct acknowledgement for Fig. 2. The corrected part of legend of Fig. 2 is given below.

5.
Semin Immunopathol ; 42(3): 355-371, 2020 06.
Artigo em Inglês | MEDLINE | ID: mdl-32076812

RESUMO

Schistosomiasis (bilharzia) is a neglected tropical disease caused by trematode worms of the genus Schistosoma. The transmission cycle involves human (or other mammalian) water contact with surface water contaminated by faeces or urine, as well as specific freshwater snails acting as intermediate hosts. The main disease-causing species are S. haematobium, S. mansoni and S. japonicum. According to the World Health Organisation, over 250 million people are infected worldwide, leading to considerable morbidity and the estimated loss of 1.9 million disability-adjusted life years (DALYs), a likely underestimated figure. Schistosomiasis is characterised by focal epidemiology and an over-dispersed population distribution, with higher infection rates in children. Complex immune mechanisms lead to the slow acquisition of immune resistance, but innate factors also play a part. Acute schistosomiasis, a feverish syndrome, is most evident in travellers following a primary infection. Chronic schistosomiasis affects mainly individuals with long-standing infections residing in poor rural areas. Immunopathological reactions against schistosome eggs trapped in host tissues lead to inflammatory and obstructive disease in the urinary system (S. haematobium) or intestinal disease, hepatosplenic inflammation and liver fibrosis (S. mansoni and S. japonicum). An effective drug-praziquantel-is available for treatment but, despite intensive efforts, no schistosomiasis vaccines have yet been accepted for public use. In this review, we briefly introduce the schistosome parasites and the immunopathogenic manifestations resulting from schistosomiasis. We then explore aspects of the immunology and host-parasite interplay in schistosome infections paying special attention to the current status of schistosomiasis vaccine development highlighting the advancement of a new controlled human challenge infection model for testing schistosomiasis vaccines.


Assuntos
Anti-Helmínticos , Esquistossomose , Vacinas , Animais , Anti-Helmínticos/uso terapêutico , Criança , Humanos , Schistosoma haematobium , Schistosoma mansoni , Esquistossomose/tratamento farmacológico , Esquistossomose/epidemiologia , Vacinas/uso terapêutico
6.
Sci Rep ; 9(1): 16207, 2019 11 07.
Artigo em Inglês | MEDLINE | ID: mdl-31700040

RESUMO

Modulating the tumor microenvironment to promote an effective immune response is critical in managing any type of tumor. Melanoma is an aggressive skin cancer and the incidence rate is increasing worldwide. Potent protease inhibitors have recently been extensively researched as potential therapeutic agents against various cancers. EgKI-1 is a potent Kunitz type protease inhibitor identified from the canine tapeworm Echinococcus granulosus that has shown anti-cancer activities in vivo. In this study we show that EgKI-1 significantly reduced the growth of melanoma in the B16-F0 mouse model and was not toxic to normal surrounding tissue. Moreover, EgKI-1 treatment significantly reduced survivin expression levels and increased the CD8+ T cell population in draining axillary lymph nodes. Therefore, EgKI-1 potentially reduces tumor growth by inducing apoptosis and modulating the tumor microenvironment, and has potential for development as an intra-lesional treatment for melanoma.


Assuntos
Echinococcus granulosus , Melanoma Experimental/tratamento farmacológico , Inibidores de Proteases/farmacologia , Animais , Cães , Feminino , Camundongos , Camundongos Endogâmicos C57BL , Inibidores de Proteases/uso terapêutico , Ensaios Antitumorais Modelo de Xenoenxerto
7.
Int J Mol Sci ; 20(7)2019 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-30925781

RESUMO

We showed previously that the Schistosoma japonicum insulin-like peptide (SjILP) binds the worm insulin receptors, thereby, activating the parasite's insulin pathway and emphasizing its important role in regulating uptake of glucose, a nutrient essential for parasite survival. Here we show that SjILP is differentially expressed in the schistosome life cycle and is especially highly transcribed in eggs, miracidia, and adult female worms. RNA inference was employed to knockdown SjILP in adults in vitro, with suppression confirmed by significantly reduced protein production, declined adenosine diphosphate levels, and reduction in glucose consumption. Immunolocalization showed that SjILP is located to lateral gland cells of mature intra-ovular miracidia in the schistosome egg, and is distributed on the ciliated epithelium and internal cell masses of newly transformed miracidia. In schistosomula, SjILP is present on the tegument in two antero-lateral points, indicating highly polarized expression during cercarial transformation. Analysis of serum from S. japonicum-infected mice by ELISA using a recombinant form of SjILP as an antigen revealed IgG immunoreactivity to this molecule at 7 weeks post-infection indicating it is likely secreted from mature eggs into the host circulation. These findings provide further insights on ILP function in schistosomes and its essential roles in parasite survival and growth in different development stages.


Assuntos
Regulação da Expressão Gênica no Desenvolvimento , Proteínas de Helminto/genética , Insulina/genética , Schistosoma japonicum/crescimento & desenvolvimento , Schistosoma japonicum/genética , Esquistossomose Japônica/parasitologia , Animais , Feminino , Proteínas de Helminto/imunologia , Imunoglobulina G/sangue , Imunoglobulina G/imunologia , Insulina/imunologia , Estágios do Ciclo de Vida , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Schistosoma japonicum/imunologia , Esquistossomose Japônica/sangue , Esquistossomose Japônica/imunologia
8.
PLoS One ; 13(8): e0200433, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30169534

RESUMO

EgKI-1, a member of the Kunitz type protease inhibitor family, is highly expressed by the oncosphere of the canine tapeworm Echinococcus granulosus, the stage that is infectious to humans and ungulates, giving rise to a hydatid cyst localized to the liver and other organs. Larval protoscoleces, which develop within the hydatid cyst, have been shown to possess anti-cancer properties, although the precise molecules involved have not been identified. We show that recombinant EgKI-1 inhibits the growth and migration of a range of human cancers including breast, melanoma and cervical cancer cell lines in a dose-dependent manner in vitro without affecting normal cell growth. Furthermore, EgKI-1 treatment arrested the cancer cell growth by disrupting the cell cycle and induced apoptosis of cancer cells in vitro. An in vivo model of triple negative breast cancer (MDA-MB-231) in BALB/c nude mice showed significant tumor growth reduction in EgKI-1-treated mice compared with controls. These findings indicate that EgKI-1 shows promise for future development as an anti-cancer therapeutic.


Assuntos
Apoptose , Neoplasias da Mama/prevenção & controle , Movimento Celular , Proliferação de Células , Echinococcus granulosus/química , Proteínas Secretadas Inibidoras de Proteinases/administração & dosagem , Animais , Neoplasias da Mama/metabolismo , Neoplasias da Mama/patologia , Ciclo Celular , Cães , Feminino , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Células Tumorais Cultivadas , Ensaios Antitumorais Modelo de Xenoenxerto
9.
Front Med (Lausanne) ; 5: 60, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29594121

RESUMO

Whereas a number of parasites are well recognized risk factors for a number of different cancers in mammalian hosts, there is limited information on the ability of parasitic organisms to induce anticancer effects. There are conflicting reports that echinococcosis, caused by the canine tapeworm Echinococcus granulosus, can decrease or increase cancer risk. This review considers both indirect anticancer effects as the result of adaptive immunity generated against certain echinococcal antigens and the direct effect of molecules released by E. granulosus whose activity directly inhibits cancer cell migration and growth. In conclusion, E. granulosus probably secretes molecules that can be developed as anticancer therapeutics in future.

10.
Int J Infect Dis ; 66: 26-32, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29128645

RESUMO

OBJECTIVE: The aim of this study was to develop a vaccine against schistosomiasis, which is a major challenge due to the complex lifecycle of the causative schistosome parasite. METHODS: SmKI-1 is a 16-kDa Kunitz-type protease inhibitor present in the excretory-secretory products and tegument of adult worms and eggs of Schistosoma mansoni. Two independent vaccine trials were performed in mice to determine the efficacy of rSmKI-1 in developing protective immunity. RESULTS: The results obtained showed reductions of 23-33% in adult worms, 28-31% in intestinal eggs, 33-39% in faecal eggs, and 20-43% in liver eggs. Furthermore, rSmKI-1 significantly increased the production of interferon gamma, interleukin (IL)-10, and IL-6 in vaccinated mice, maintaining a Th1/Th2-type balanced protective response. CONCLUSIONS: rSmKI-1 generated partial protection against schistosomiasis mansoni in the murine model of infection and could be developed as part of a combination vaccine with other vaccine candidates to provide an even more solid level of protection.


Assuntos
Antígenos de Helmintos , Inibidores de Proteases , Esquistossomose mansoni/prevenção & controle , Vacinas , Animais , Antígenos de Helmintos/imunologia , Hipersensibilidade a Ovo , Feminino , Interferon gama , Interleucina-10 , Interleucina-6 , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Inibidores de Proteases/imunologia , Schistosoma mansoni , Esquistossomose mansoni/imunologia , Vacinas/imunologia
11.
Trends Parasitol ; 33(5): 400-413, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-28089171

RESUMO

Protease inhibitors play crucial roles in parasite development and survival, counteracting the potentially damaging immune responses of their vertebrate hosts. However, limited information is currently available on protease inhibitors from schistosomes and food-borne trematodes. Future characterization of these molecules is important not only to expand knowledge on parasitic fluke biology but also to determine whether they represent novel vaccine and/or drug targets. Moreover, protease inhibitors from flukes may represent lead compounds for the development of a new range of therapeutic agents against inflammatory disorders and cancer. This review discusses already identified protease inhibitors of fluke origin, emphasizing their biological function and their possible future development as new intervention targets.


Assuntos
Interações Hospedeiro-Parasita/imunologia , Inibidores de Proteases/imunologia , Trematódeos/fisiologia , Infecções por Trematódeos/enzimologia , Infecções por Trematódeos/parasitologia , Animais , Descoberta de Drogas , Humanos , Inflamação/tratamento farmacológico , Neoplasias/tratamento farmacológico , Inibidores de Proteases/uso terapêutico , Trematódeos/enzimologia , Trematódeos/imunologia , Infecções por Trematódeos/imunologia
12.
PLoS Negl Trop Dis ; 9(12): e0004268, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26645974

RESUMO

The tapeworm Echinococcus granulosus is responsible for cystic echinococcosis (CE), a cosmopolitan disease which imposes a significant burden on the health and economy of affected communities. Little is known about the molecular mechanisms whereby E. granulosus is able to survive in the hostile mammalian host environment, avoiding attack by host enzymes and evading immune responses, but protease inhibitors released by the parasite are likely implicated. We identified two nucleotide sequences corresponding to secreted single domain Kunitz type protease inhibitors (EgKIs) in the E. granulosus genome, and their cDNAs were cloned, bacterially expressed and purified. EgKI-1 is highly expressed in the oncosphere (egg) stage and is a potent chymotrypsin and neutrophil elastase inhibitor that binds calcium and reduced neutrophil infiltration in a local inflammation model. EgKI-2 is highly expressed in adult worms and is a potent inhibitor of trypsin. As powerful inhibitors of mammalian intestinal proteases, the EgKIs may play a pivotal protective role in preventing proteolytic enzyme attack thereby ensuring survival of E. granulosus within its mammalian hosts. EgKI-1 may also be involved in the oncosphere in host immune evasion by inhibiting neutrophil elastase and cathepsin G once this stage is exposed to the mammalian blood system. In light of their key roles in protecting E. granulosus from host enzymatic attack, the EgKI proteins represent potential intervention targets to control CE. This is important as new public health measures against CE are required, given the inefficiencies of available drugs and the current difficulties in its treatment and control. In addition, being a small sized highly potent serine protease inhibitor, and an inhibitor of neutrophil chemotaxis, EgKI-1 may have clinical potential as a novel anti-inflammatory therapeutic.


Assuntos
Echinococcus granulosus/metabolismo , Inibidores de Proteases/metabolismo , Animais , Clonagem Molecular , Echinococcus granulosus/genética , Expressão Gênica , Humanos , Camundongos , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Especificidade por Substrato
13.
Parasitology ; 142(14): 1663-72, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26463744

RESUMO

Little is known about the molecular mechanisms whereby the human blood fluke Schistosoma japonicum is able to survive in the host venous blood system. Protease inhibitors are likely released by the parasite enabling it to avoid attack by host proteolytic enzymes and coagulation factors. Interrogation of the S. japonicum genomic sequence identified a gene, SjKI-1, homologous to that encoding a single domain Kunitz protein (Sjp_0020270) which we expressed in recombinant form in Escherichia coli and purified. SjKI-1 is highly transcribed in adult worms and eggs but its expression was very low in cercariae and schistosomula. In situ immunolocalization with anti-SjKI-1 rabbit antibodies showed the protein was present in eggs trapped in the infected mouse intestinal wall. In functional assays, SjKI-1 inhibited trypsin in the picomolar range and chymotrypsin, neutrophil elastase, FXa and plasma kallikrein in the nanomolar range. Furthermore, SjKI-1, at a concentration of 7·5 µ m, prolonged 2-fold activated partial thromboplastin time of human blood coagulation. We also demonstrate that SjKI-1 has the ability to bind Ca(++). We present, therefore, characterization of the first Kunitz protein from S. japonicum which we show has an anti-coagulant properties. In addition, its inhibition of neutrophil elastase indicates SjKI-1 have an anti-inflammatory role. Having anti-thrombotic properties, SjKI-1 may point the way towards novel treatment for hemostatic disorders.


Assuntos
Fatores de Coagulação Sanguínea/antagonistas & inibidores , Inibidores de Proteases/metabolismo , Schistosoma japonicum/metabolismo , Sequência de Aminoácidos , Animais , Aprotinina/genética , Aprotinina/imunologia , Aprotinina/metabolismo , Cálcio/metabolismo , Bovinos , Análise por Conglomerados , Feminino , Regulação da Expressão Gênica no Desenvolvimento , Humanos , Masculino , Camundongos , Inibidores de Proteases/química , Inibidores de Proteases/imunologia , Estrutura Secundária de Proteína , Coelhos , Schistosoma japonicum/genética , Alinhamento de Sequência , Caramujos
14.
Parasit Vectors ; 8: 408, 2015 Aug 04.
Artigo em Inglês | MEDLINE | ID: mdl-26238343

RESUMO

BACKGROUND: Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the host immune system. Protease inhibitors likely play a critical role in host immune modulation thereby promoting parasite survival in this extremely hostile environment. Even though Kunitz type serine protease inhibitors have been shown to play important physiological functions in a range of organisms these proteins are less well characterised in parasitic helminths. METHODS: We have cloned one gene sequence from S. mansoni, Smp_147730 (SmKI-1) which is coded for single domain Kunitz type protease inhibitor, E. coli-expressed and purified. Immunolocalisation and western blotting was carried out using affinity purified polyclonal anti-SmKI-1 murine antibodies to determine SmKI-1 expression in the parasite. Protease inhibitor assays and coagulation assays were performed to evaluate the functional roles of SmKI-1. RESULTS: SmKI-1 is localised in the tegument of adult worms and the sub-shell region of eggs. Furthermore, this Kunitz protein is secreted into the host in the ES products of the adult worm. Recombinant SmKI-1 inhibited mammalian trypsin, chymotrypsin, neutrophil elastase, FXa and plasma kallikrein with IC50 values of 35 nM, 61 nM, 56 nM, 142 nM and 112 nM, respectively. However, no inhibition was detected for pancreatic elastase or cathepsin G. SmKI-1 (4 µM) delayed blood clot formation, reflected in an approximately three fold increase in activated partial thromboplastin time and prothrombin time. CONCLUSIONS: We have functionally characterised the first Kunitz type protease inhibitor (SmKI-1) from S. mansoni and show that it has anti-inflammatory and anti-coagulant properties. SmKI-1 is one of a number of putative Kunitz proteins in schistosomes that have presumably evolved as an adaptation to protect these parasites from the defence mechanisms of their mammalian hosts. As such they may represent novel vaccine candidates and/or drug targets for schistosomiasis control.


Assuntos
Regulação da Expressão Gênica/fisiologia , Proteínas de Helminto/metabolismo , Inibidores de Proteases/metabolismo , Schistosoma mansoni/metabolismo , Sequência de Aminoácidos , Animais , Clonagem Molecular , DNA de Helmintos , Proteínas de Helminto/genética , Dados de Sequência Molecular , Filogenia
15.
Dev Comp Immunol ; 39(3): 219-27, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23186642

RESUMO

Kunitz type proteins are an important group of ubiquitous protease inhibitors found spanning the evolutionary tree from microbes to mammals. These proteins can have single or multiple Kunitz inhibitory domains linked together, or associated with other domain types. The Kunitz motif comprises a chain of around 60 amino acid residues stabilized by three disulphide bonds. The inhibitory specificity of the Kunitz domain varies with the particular amino acids at the reactive sites and exhibit canonical inhibition. In vertebrates, Kunitz inhibitors play a major role in inflammatory processes while in invertebrates involve in a range of diverse functional roles. This review discusses the structure, mechanism of action and functions of invertebrate Kunitz inhibitors. Venomous invertebrates such as scorpions, cone snails have either Kunitz inhibitors with both neurotoxic and protease inhibitory activity or typical Kunitz type toxins. In parasitic helminths these inhibitors play a major role in providing protection from host digestive protease enzymes. Several proteins having Kunitz domains in nematodes are involved in collagen biosynthesis while some induce IgE-mediated allergic reactions. Most Kunitz inhibitors in blood sucking arthropods function as anti-coagulant factors and several act as a defense against microbial pathogen invaders.


Assuntos
Peptídeos Catiônicos Antimicrobianos/metabolismo , Aprotinina/química , Hipersensibilidade/enzimologia , Inibidores de Serina Proteinase/química , Animais , Apoptose , Aprotinina/fisiologia , Coagulação Sanguínea , Colágeno/biossíntese , Imunidade Ativa , Invertebrados , Neurônios/metabolismo , Homologia de Sequência de Aminoácidos , Inibidores de Serina Proteinase/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...